Studies of epigenetic modifications would benefit from improved methods for high-throughput methylation profiling. We introduce two complementary approaches that use next-generation sequencing technology to detect cytosine methylation. In the first method, we designed B10,000 bisulfite padlock probes to profile B7,000 CpG locations distributed over the ENCODE pilot project regions and applied them to human B-lymphocytes, fibroblasts and induced pluripotent stem cells. This unbiased choice of targets takes advantage of existing expression and chromatin immunoprecipitation data and enabled us to observe a pattern of low promoter methylation and high gene-body methylation in highly expressed genes. The second method, methyl-sensitive cut counting, generated nontargeted genome-scale data for B1.4 million HpaII sites in the DNA of B-lymphocytes and confirmed that gene-body methylation in highly expressed genes is a consistent phenomenon throughout the human genome. Our observations highlight the usefulness of techniques that are not inherently or intentionally biased towards particular subsets like CpG islands or promoter regions.
Methylation of cytosine at CpG dinucleotides is an important regulatory modification in many eukaryotic genomes 1 . CpG methylation can be inherited through ''maintenance methylation'' of hemimethylated sites in newly synthesized DNA and plays a role in gene transcription, embryogenesis and diseases such as cancer [2] [3] [4] . It is generally studied using one of three techniques. The first, bisulfite sequencing, converts all unmethylated cytosines to uracil, which is subsequently recognized as thymine 5 . Although it has emerged as the 'gold standard' for methylation profiling, bisulfite sequencing is complicated by the decrease in sequence specificity associated with conversion of most cytosines in the genome. The second approach involves restriction enzymes that preferentially cut DNA based on its methylation status, typically when the recognition site is unmethylated 6 . Although robust, this method is limited to profiling the enzyme's recognition sites. Finally, some recent studies have used antibody-based affinity purification to pull down methylated DNA [7] [8] [9] . As this approach is based on the methylcytosine density in a region, it is more effective for profiling regions with a higher density of potentially methylated CpG sites. Strategies involving bisulfite sequencing, methylation-sensitive restriction enzymes and affinity purification have all been combined with microarrays 7,9-15 or high-throughput sequencing [16] [17] [18] to create high-throughput methylation profiles. But most of these approaches have been limited by choice or by technology to CpG islands and/or gene promoters.
Although whole genome bisulfite sequencing has been used for genome-wide analysis of methylation in Arabidopsis thaliana 17, 18 , it remains prohibitively expensive for the much larger human genome. We therefore developed two complementary technologies, both involving massively parallel sequencing 19, 20 , for high-throughput profiling of cytosine methylation and applied them to eight human cell lines. We used the first, a targeted approach involving padlock (molecular inversion) probes designed to recognize locations in bisulfite-treated genomic DNA, to specifically capture and profile B7,000 CpG sites in the ENCODE pilot project regions 21 . The second method, which uses the methylation sensitive enzyme HpaII and is thus called methylsensitive cut counting (MSCC), was used to create a genome-scale methylation profile of a single cell line. MSCC uses a library derived from all locations cut by HpaII to profile the methylation of B1.4 million unique sites in the human genome.
Our methylation profiles consistently reveal a pattern of gene-body methylation in the highly expressed genes of human cell lines. This builds on growing evidence for gene-body methylation in mammals 9, 10, 22 and shows it to be a general feature of all highly expressed genes in human cell lines. Our results also support prior observations that genes with promoters containing an intermediate level of CpG density have the highest expression-related differences in promoter methylation.
profiling. Padlock probes are B100-nucleotide DNA fragments designed to hybridize to genomic DNA targets in a horseshoe manner (Fig. 1a) [23] [24] [25] . After the gap between the two hybridized, locus-specific arms of a padlock probe is polymerized and ligated to form a circular strand of DNA, the circles generated can then be amplified using the common 'backbone' sequence that connects the two arms. This enables tens of thousands of probes to be used within a single reaction. The resulting libraries are then analyzed using massively parallel sequencing. We have used padlock probes to specifically amplify B10,000 human exons 25 , and have recently improved capturing efficiency 410,000-fold (Li et al., unpublished data).
To apply padlock probes to profiling DNA methylation, we designed a probe set to target B10,000 locations in bisulfite-treated human genomic DNA (Supplementary Table 1 online) . Bisulfite treatment converts all unmethylated cytosines to uracils, which are recognized as thymines 5 . To simplify the construction of sequencing libraries, probes were designed to target 10-nucleotide regions containing at least one CpG (Fig. 1a) . Nonetheless, it should be possible to also capture larger regions 25 . Hybridizing arms flanking this span were designed to avoid CpGs because their methylation status (and sequence after bisulfite treatment) is unknown. This simplified the design, although it should also be possible to design probes that match all potential variants 26 . To avoid targeting unconverted DNA, one of the arms was required to have at least three non-CpG cytosines in the fifteen nucleotides closest to the span.
Probes were chosen from within the ENCODE pilot project regions, which represent B1% of the human genome and have been characterized by expression and chromatin immunoprecipitation (ChIP) analysis 21 . Rather than targeting promoter regions or CpG islands, we chose B10,000 probes that best satisfied our design criteria scattered over all regions (Supplementary Table 2 online). Because we avoided CpGs in the hybridizing arms, these probes were actually biased against targeting CpG islands that are favored by most of previous methylation studies.
The probes, flanked with common primer sequences ('probe precursors'), were synthesized on a programmable microarray and cleaved into a single tube, as described previously 25 . After PCR amplification, the probe precursors were subject to enzymatic processing to trim both primer ends.
Performance of the BSPP assay Our initial experiment used the BSPP set to investigate cytosine methylation in the Epstein-Barr virus (EBV)-transformed GM06990 B-lymphocyte cell line, also used in the ENCODE project 21 . The pool of B10,000 BSPPs was hybridized with the bisulfite-converted genomic DNA of GM06990 in a single reaction. After the circles were formed and subsequently amplified (Fig. 1a) , we gel-extracted DNA of the expected size ( Supplementary Fig. 1a online) and cloned and sequenced individual library molecules to check the specificity of capture. Of the 79 isolates tested, 78 (99%) mapped to the intended target sites and were unique, illustrating the high specificity of padlock-probe technology despite the reduced genomic complexity after bisulfite conversion. We performed two technical replicates of target capture followed by Illumina Genome Analyzer (formerly Solexa) sequencing. Although the number of probe observations varied widely, B7,700 (80%) and B6,400 (68%) sites were covered with at least 1 and 10 reads, respectively, when B3 million reads were derived from a single sequencing lane ( Supplementary Fig. 1b and Supplementary Table 3 online). Nevertheless, both the numbers of probe observations ( Supplementary Fig. 1c ) and the inferred methylation levels (Fig. 1b) were highly correlated. Because of this, if reduced variance is desired, probes can be empirically divided into separate pools, depending on their efficiencies 26 . To rule out the possibility of systemic bias, we performed traditional Sanger sequencing on 33 regions amplified from bisulfite-treated DNA (Supplementary Table 4 online); the methylation levels determined by this method correlated well with the BSPP-determined methylation (r ¼ 0.966; Fig. 1c) .
Methylation levels were bimodally distributed, with most sites o20% or 480% methylated ( Supplementary Fig. 2 online) . This is consistent with previous reports 27 . As CpGs in close proximity are known to be often co-methylated 27 , we took advantage of the clonal feature of Illumina sequencing to investigate whether co-methylation occurs at the single-molecule level. Within probes spanning more than one CpG, sites with intermediate methylation levels (between 20% and 80%) displayed a positive correlation with the methylation states of neighboring CpGs on individual strands ( Supplementary  Fig. 3 online) . 
Methylation versus transcription and histone modification
To explore the relationship between gene expression and methylation in the promoter and elsewhere in the gene, we used ENCODE project gene expression data for the same cell line (GM06990) to split genes into two equal groups: ''highly expressed'' and ''weakly expressed'' genes. For each group we plotted median cytosine methylation against gene position (Fig. 2a ). In the highly expressed genes, we saw a pattern of low methylation in the promoter region and considerable methylation in the rest of the gene body. The weakly expressed genes were moderately methylated in both promoter and gene-body regions. Cytosine methylation may interact with other epigenetic features, such as histone modifications. To look for correlations between DNA methylation and histone modification, we compared available ChIP data 21 with our methylation data obtained from the same cell line. Cytosine methylation was correlated with H3K36 methylation and anticorrelated with H3K27 methylation ( Supplementary Fig. 4 online) . These correlations probably reflect the distribution of our probes, half of which target regions within gene bodies, whereas only 5% target regions within 1 kb of transcription start sites. The correlations are consistent with the gene-body pattern of the histone modifications: H3K36 methylation is higher in gene bodies of highly expressed genes, whereas H3K27 is high in gene bodies of weakly expressed genes 28 .
BSPP profiling of cell lines from the Personal Genome Project Our methylation profiling methods have, in part, been developed as a pilot for studying epigenomics within the context of the Personal Genome Project (PGP), a program through which researchers will deeply explore the relationship between genotype and phenotype through collection of multi-faceted biological information from individuals registered within the project 29 . To explore how methylation patterns vary between different cell types and different individuals, we applied the ENCODE BSPP set to several cell lines from the PGP: PGP1 and PGP9 EBV-transformed B-lymphocytes, PGP1 and PGP9 fibroblasts, and induced pluripotent stem (iPS) cells derived from PGP1 and PGP9 fibroblasts. Consistent with previous studies 27 , the methylation patterns of lymphoblast lines derived from different individuals were highly correlated (r ¼ 0.85, Supplementary  Fig. 5a online), whereas the correlation between fibroblast and lymphoblast cells from the same individual was much lower (r ¼ 0.63, Supplementary Fig. 5b ). The PGP1 and two independent PGP9-derived iPS cell lines were hypermethylated in the ENCODE regions of B400 genes, compared to the fibroblast line from which they were derived (Supplementary Figs. 2f-h and 5c,d). This may be a general phenomenon, although because we surveyed a limited set of locations and cell culturing can affect global methylation levels 16 , further investigation is warranted. The phenomenon of gene-body methylation in highly expressed genes was also observed in the PGP lymphoblast and fibroblast cell lines ( Supplementary Fig. 6 online).
MSCC assay
In contrast with the BSPP approach, our second technology, MSCC, profiles methylation across the whole genome. MSCC queries the sensitivity of all CCGG sites within the genome to HpaII, a methylation-sensitive restriction enzyme that cuts unmethylated CCGG sequences. Methylation-sensitive restriction enzymes typically have a recognition site that contains a CpG dinucleotide and are blocked from cutting if that site is methylated 6 . The MSCC assay is not limited to using HpaII and could be used with other methylationsensitive restriction enzymes to profile other, nonoverlapping genomescale sets of CpGs (Supplementary Table 5 online). These sets could be combined to created denser genome-scale profiles.
With MSCC, no choice is made for which sites are targeted-all uniquely identifiable HpaII sites are profiled. HpaII sites have a distribution similar to the distribution of all CpG dinucleotides (Supplementary Table 2 fragments from all cut locations and then using massively parallel sequencing to gather millions of observations of these, we can infer the methylation level by the number of times a site is observed (Fig. 3a) .
Sites with many and no reads are inferred to have low and high methylation levels, respectively. A control library was also constructed by replacing HpaII with a methylation-insensitive isoschizomer, MspI. However, sequencing an MspI control is a large additional cost and our data indicate that results from the HpaII library alone are highly correlated with methylation at individual sites. The human genome contains 2.3 million HpaII sites and each of these, if cut, can generate two possible library tags. Of the B4.6 million possible tag sequences, we considered about half (B2.3 million) to be sufficiently unique for use in profiling: they have more than a single one-nucleotide difference when compared with any other possible sequence. These tags combine to cover a total of 1,417,432 individual CpG sites (Supplementary Table 6 online). Of these, 888,455 (63%) produce two unique tags ('paired tags') and 528,977 (37%) produce a single unique tag. These combine to a total of 1,417,432 CpG sites that are profiled with this method (Supplementary Table 6 online). Nearly half of these sites occur within genes (418,000 genes have at least one site within them), 3.4% are within 1 kb of the transcription start site (410,000 genes have at least one site in this region) and 13.5% are within CpG islands (90% of CpG islands have at least one site within them) (Supplementary Table 2 ).
MSCC profiling accurately measures methylation
We produced an MSCC HpaII library and MspI control library for the PGP1 EBV-transformed B-lymphocyte cell line, for which we also had BSPP and gene expression data. Libraries were sequenced using an Illumina Genome Analyzer and matched to a list of all possible tag sequences (Supplementary Table 7 online). We performed two technical replicates of the HpaII library that, although subject to variance according to the Poisson distribution, showed a high correlation in the number of observations for each site (r ¼ 0.82, Supplementary Fig. 7 online) . The availability of BSPP data for the same sample enabled us to compare the methylation levels determined by BSPPs with MSCC HpaII data for 381 sites (726 individual tags) ( Supplementary Fig. 8 online) . When data are binned according to the BSPP-determined methylation levels, the average number of © 2009 Nature America, Inc. All rights reserved. counts for each bin is linearly related to its methylation level (Fig. 3b) . We used this to estimate average methylation levels when counts for multiple sites are averaged. BSPP methylation data can also be used to estimate methylation levels for individual sites based on MSCC HpaII counts ( Fig. 3c and Supplementary Fig. 9 online) .
MSCC counts have more noise for more highly digested HpaII sites (that is, sites with lower methylation). As a result, MSCC is more accurate at distinguishing moderately methylated sites from highly methylated sites than it is for distinguishing moderately from weakly methylated sites, although deeper sequencing coverage should improve accuracy (Supplementary Table 8 online) . In addition, preliminary data suggest that the accuracy can be improved by sequencing an 'inverse library' of methylated CCGG sites, which is constructed by dephosphorylating HpaII-digested fragment ends, digesting with MspI and then ligating an MmeI-containing adaptor to generate sequencing tags ( Supplementary Fig. 10 online) . In the following analyses, however, we used only the MSCC HpaII data generated from three lanes of Illumina sequencing.
Comparison of MSCC methylation with gene expression
Compared to BSPP, which analyzed several thousand data points covering B400 genes, the MSCC technology covered 1.4 million sites in 418,000 genes distributed over the entire genome. This allowed us to examine the relationship between gene expression and cytosine methylation more thoroughly. We split genes into five equal groups based on their expression levels and plotted the running average of MSCC observations versus gene position for each (Figs. 2b-d) . We observed a similar pattern of low promoter methylation and considerable gene-body methylation in highly expressed genes as we did in the BSPP assays (Fig. 2b and Supplementary Fig. 6a ). Previous studies have indicated that gene expression may require low promoter methylation extending several hundred bases into the gene 30 . Consistent with this, we observed that highly expressed genes have low methylation, extending to around +1 kb downstream of the transcription start site with a valley at around 600-700 bp (Fig. 2c) . Our data also show another valley upstream of the transcription start site. The pair of valleys is similar to the double peaks observed in H3K4 methylation and other histone modifications 28 and may be related to recent findings of bidirectional transcription at gene promoters 31 . At the 3¢ end, highly expressed genes appear to have increased methylation running up to and dropping off after the end of the gene (Fig. 2d) .
Previous experiments have indicated that the relationship between promoter methylation and gene expression is related to the CpG density of the promoter 32 . To examine this, we divided promoters into three types according to CpG content: high CpG promoters, low CpG promoters and intermediate CpG promoters. Our results, which are consistent with previous observations, provide quantitative averaged profiles of methylation versus position for each promoter type (Fig. 4) . Although subtle expression-related differences exist, on average, high CpG promoters have less methylation (Fig. 4a) , whereas low CpG promoters display more methylation (Fig. 4c) , regardless of gene expression level. Our results also show that the largest expression-related differences in promoter methylation are found in intermediate CpG promoters (Fig. 4b) .
To explore how methylation information was correlated with gene expression on the level of individual genes, we compared the gene promoter methylation and gene-body methylation of individual genes. According to these two metrics, genes formed two clusters that corresponded to high and low expression levels (Fig. 5 ). This figure shows that the average gene-body methylation differences observed between highly expressed and weakly expressed genes reflect a consistent phenomenon rather than a subset of genes containing hypermethylated or hypomethylated gene bodies.
DISCUSSION
The rapid development of cheaper, massively parallel sequencing technologies 33 is opening the way for new strategies to study biologically important processes [34] [35] [36] , including the regulatory roles of epigenetic modifications like DNA methylation [16] [17] [18] . These methods are contributing to the emergence of high-throughput sequencing as a ubiquitous convergent platform. The digital aspect of sequencing makes techniques inherently more quantitative, accurate and reproducible than more traditional molecular techniques. BSPP and MSCC are two complementary methods that take advantage of the power of new sequencing technologies to profile cytosine methylation at singlebase resolution in targeted and genome-scale surveys, respectively.
In contrast to other restriction enzyme-based profiling methods 10, 11, 15 , MSCC does not involve selection of fragments within a specified size range. As a consequence, by design, its efficiency and accuracy for profiling each site is not influenced by local sequence characteristics, such as recognition-site density. MSCC also takes advantage of high-throughput sequencing technology, which is rapidly becoming cheaper, and becomes more accurate when more sequencing reads are obtained. Although reduced representation bisulfite sequencing (RRBS) also involves massively parallel sequencing to profile methylation at a subset of sites 16 , it cannot be designed to target specific segments (as BSPP can) and is biased by profiling a scattered set of genomic segments with high CpG density. In contrast, MSCC is less biased, as HpaII sites are more evenly distributed throughout the genome.
Gene-body methylation has been observed in Arabidopsis thaliana 12, 13, 17, 18 , where it is associated with active genes. Methylation in the gene bodies of certain mammalian genes has long been known to be positively correlated with elevated expression 37 , and there is now growing evidence that this may be a general phenomenon. Gene-body methylation has been observed in the active human X chromosome when compared to its inactive counterpart 10 Figure 5 Methylation profiles of individual genes. Individual genes are plotted according to the average number of MSCC HpaII counts found in the promoters (horizontal axis, -400 to +1,000 relative to start) and gene bodies (vertical axis, between the gene end and +2,000 relative to start). The color of each point reflects the expression level of that gene. Points were plotted in a random order to avoid artifacts produced by nonrandom overlaps. Only genes with at least ten data points in each region were used in the analysis.
cancer cell lines 22 , and methylation of CpG-rich sites in gene bodies has been associated with highly expressed genes in human B cells 9 . A general phenomenon of gene-body methylation in highly expressed genes is strongly supported by our data obtained using both the BSPP and MSCC assays. Gene-body methylation has been hypothesized to suppress spurious initiation of transcription within active genes in Arabidopsis 12,13 and a similar function may exist in mammals 1 . CpG islands and promoters have been the preferred target of many studies and have, in the past, guided the design of many methylation profiling experiments 14, 16, 32, 38 . Our observations concerning genebody methylation, differential methylation in intermediate CpG promoters 32 , and other evidence for differential methylation in regions outside CpG islands and promoters 15 , underscore the importance of less biased profiling methods in uncovering aspects of methylation that might otherwise have been missed. As DNA sequencing costs drop, tools like BSPP and MSCC could soon be broadly applied to study the epigenomic changes associated with developmental shifts, environmental changes, and disease states.
METHODS
Cell lines, RNA and genomic DNA, expression profiling, and bisulfite treatment. Genomic DNA of GM06990 (a HapMap/ENCODE sample) was obtained from Coriell Cell Repository. With the approval of Harvard Medical School's Institutional Review Boards, blood and skin biopsies were obtained from donors of the Personal Genome Project. The EBV-transformed B-lymphocyte cell lines and the derivative genomic DNA for donors PGP1 (GM20431) and PGP9 (GM21833) were generated and acquired from Coriell Cell Repository. Genomic DNA obtained directly from Coriell was used for methylation analysis of these lines, cultured cell lines were used for gene expression profiling. The primary fibroblast lines for PGP1 and PGP9 were generated by and obtained from Brigham Women's Hospital. The cultured cell line was used for both genomic DNA and gene expression profiling.
The PGP1 iPS line and two PGP9 iPS cell lines were derived by infecting primary human fibroblasts of PGP1 and PGP9 with highly concentrated retroviral OCT3, KLF4, SOX2 and c-MYC particles 39 . The infected cells were trypsinized onto a feeder layer after 4 d and maintained in hES medium (KO-DMEM (Invitrogen), 20% KO-SR (Invitrogen), 1Â l-glutamine (Gibco), 1Â MEM NEAA (Gibco), 1Â penicillin/streptomycin (Gibco), 55 mM mercaptoethanol and 10 ng/ml bFGF). The iPS colonies were identified by their characteristic morphology after 3-4 weeks.
Immortalized lymphocytes were cultured in RPMI-1640 medium (Invitrogen) with 10% FBS (Invitrogen) and 2 mM L-glutamine. Primary fibroblasts were cultured in DMEM/F12 medium (Invitrogen) with 15% FBS and 10 ng/ml EGF. Human iPS cell lines were grown on a feeder layer of mouse embryonic fibroblasts (Global Stem) in hES media, and mechanically separated from mouse cells before DNA/RNA extraction.
Genomic DNAs and total RNAs were extracted with AllPrep DNA/RNA/ Protein Mini Kit (Qiagen). RNA gene expression profiling was done using Illumina's bead array technology through the service provided by Harvard Partner Center for Genetics and Genomics. Bisulfite treatment was performed using the EZ DNA Methylation-Gold Kit (Zymo Research). Typical yield was 50-75% after bisulfite conversion.
Bisulfite padlock probe design and synthesis. Files for genomic sequence for the ENCODE pilot project regions were obtained from UCSC. Potential locations were chosen from nonrepetitive sequences containing 10 bases with a 5¢ CpG flanked by least 20 bases of CpG-free flanking sequence on each side. Flanking arm sequences were designed for either bisulfite-treated strand, up to 28 bases in length, avoiding CpGs and targeting a melting temperature range of 50-55 1C. The 'ligation arm' was required to contain at least three non-CpG cytosines, and a guanine content of at least 20% was required of both arms. Probes were then selected to optimize uniqueness measurements based on 15-mer frequencies and BLAST searches for near matches. To avoid selfhybridization, no overlap between probes was allowed in the final set. Final probe sequences were 106 bp in length: two arms 28 bp long (random sequence to 28 bp, if necessary) and a 50-bp common backbone sequence. The final set of 9,552 probe sequences and locations as well as number of observations and methylation estimates from each sample is provided in Supplementary Table 1 .
Probes were synthesized using a programmable microarray (Agilent) as 150-bp oligos containing common end sequences. These were cleaved off and collected in a single tube with an estimated concentration of 0.18 fmol/species. To amplify, we took 1% of the oligos and performed real-time PCR, monitoring the amplicon in a 100-ml reaction assembled with Platinum Taq supermix, 50 pmol of each primer, and 0.5Â SYBR green. One of the primers was designed to contain phosphorothioates between the first four 5¢ bases and a 3¢ uracil. The other primer contained the sequence GATC at the 3¢ end. The PCR program was: 95 1C for 5 min, 15 cycles of 95 1C for 30 s/58 1C for 1 min/72 1C for 1 min, and finally 72 1C for 5 min. The PCR product was purified with Qiagen PCR purification kit and quantified. Using a 96-well plate, a total of 9.6 ml PCR reaction was set up with 25 fmol template along with Platinum Taq supermix, 4.8 nmol of each primer, and 0.5Â SYBR Green. The same PCR program was used. PCR products were purified by phenol:chloroform followed by Qiagen PCR purification kit and a total of 37 mg of DNA was obtained.
The PCR product was split into eight reactions with 10 units of lambda exonuclease (New England Biolabs (NEB)) in 1Â lambda exonuclease reaction buffer and incubated at 37 1C for 45 min then 75 1C for 15 min. After being purified with QiaQuick columns the single-stranded (ss)DNA was quantified with Nanodrop to be 33 ng/ml in 200 ml total. This was split into four tubes, each of which was assembled with 50 ml of ssDNA (33 ng/ml), 6 ml of 10Â DpnII reaction buffer, and 2 ml of 100 mM 'guide oligo' designed to hybridize to the 3¢ end of the ssDNA and ending in GATCNN. The mixture was heated to 95 1C for 5 min, followed by a ramp to 60 1C at 0.1 1C/s, 60 1C for 10 min, then 37 1C for 1 min. Into each tube, 5 ml of DpnII (10 units/ml) (NEB) and 5 ml of USER enzyme (1 unit/ml) (NEB) were added and these were incubated at 37 1C for 3 h. The final product was loaded into 6% TBE Urea precast polyacrylamide gels (Invitrogen) and the desired band was cut and purified. The final concentration of padlock probes was quantified on a gel to be 9 ng/ml, which is 257 nM (27 pM for each of 9,552 species).
CpG padlock capturing and sequencing library construction. We assembled 1 mg (B0.5 amol of haploid) bisulfite-treated genomic DNA in a 15 ml reaction with 1Â Ampligase buffer and 33.5 ng (B1 pmol) of probes. The reaction was incubated at 95 1C for 10 min, ramped to and held at 64 1C for 5 h, 65 1C for 5 h, 60 1C for 24 h. At 60 1C we added the gap filling and sealing mix: 2 ml of Ampligase storage buffer containing 0.5 pmol of dNTPs, 2 units Taq Stoffel fragment (Applied Biosystems), and 2.5 units Ampligase (Epicenter). The reaction was then incubated at 60 1C for 2 h, then cycled five times with 95 1C for 2 min/60 1C for 5 h. The temperature was then lowered to 37 1C and 2 ml of exonuclease I (20 units/ml) (USB) and 2 ml exonuclease II (200 units/ml) (USB) were added. The reaction was incubated at 37 1C for 2 h followed by 94 1C for 5 min.
The circularized probes were amplified using primers matching the backbone sequences in two 100 ml reactions containing 10 ml of the above reaction product, 50 ml of 2Â iQ SYBR Green supermix (Bio-Rad) and 40 pmol each primer. Real-time PCR was used to monitor the reaction, which used this BSPP library sequencing and analysis. Libraries were diluted to 10 nM and each was sequenced with one lane of an Illumina Genome Analyzer. Reads were matched with BLAST to a custom database containing the predicted reads, with CpG cytosines replaced with N, and accepted only if they had no mismatches in the 10-bp span (except the masked CpG cytosines) and not more than three mismatches elsewhere. Methylation was determined by the number of 'C' reads out of all reads for a given location.
To validate methylation levels determined by padlock probes we designed primers targeting 33 of the profiled locations in bisulfite-treated DNA, performed PCR amplification and Sanger sequencing of the PCR product. The methylation level of each site was determined using the ratio of T peak at the target location compared to neighboring non-CpG T peaks, with peak height determined using PeakPicker software 40 . This is similar to the principle applied in the commercially available software ESME 41 . Because we performed multiple sequencing reactions and from both directions, multiple estimates were combined to get the average and s.d. values we plotted for each site.
RNA expression data were gathered using the ENCODE project PolyA+ RNA signal track downloaded from UCSC. Using scores for regions annotated as exons by RefGene, median values were taken to represent gene expression level. To construct average gene graphs, each methylation data point was assigned position information according to its location relative to nearby genes: a fractional value if within a gene, or bp if upstream or downstream. The running median and quartiles were plotted.
Histone modification data were acquired from Sanger ChIP data downloaded from UCSC. To look for correlations, raw ChIP scores versus methylation were plotted along with the running median and quartiles. Gene profiles of histone modifications were also created as done for methylation data.
MSCC library creation. Two custom adapters were created for MSCC, each composed of two oligonucleotides ordered from IDT. Adapter A contains an 5¢ MmeI recognition site and 5¢ CG overhang, adapter B contains a 3¢ NN overhang.
To construct the MSCC HpaII library, 2 mg of PGP1 lymphocyte genomic DNA was assembled into a 100-ml reaction with 20 units HpaII (NEB) in 1Â NEBuffer 1, incubated at 37 1C for 2 h, then 65 1C for 20 min. To this was added 1.66 ml of 10 mM adaptor A, 12 ml 10 mM ATP and 120 units T4 DNA ligase (NEB). This was incubated at 16 1C for 4 h, then 65 1C for 15 min. Ethanol precipitation was performed and DNA was resuspended to 50 ml with a reaction mixture containing 8 units Bst DNA polymerase fragment (NEB), 200 mM dNTP and 1Â thermopol buffer (NEB). This was incubated at 50 1C for 20 min, then 85 1C for 20 min. Ethanol precipitation was performed again, and the pellet was resuspended to 50 ml with a reaction mixture containing 2 units MmeI (NEB), 50 mM SAM and 1Â NEBuffer 4. This was incubated at 37 1C for 2 h, then 80 1C for 20 min. To this was added 1.66 ml of 10 mM adaptor B, 6 ml 10 mM ATP and 3 ml T4 DNA ligase, and the mixture was incubated at 16 1C for 4 h, then 65 1C for 15 min.
The mixture was run on a 6% nondenaturing TBE polyacrylamide gel (Invitrogen) and the target band at B140 bp was purified. PCR was then performed on B80% of this purified sample using primers matching the sequences of adaptor A and adaptor B. The assembled mixture was 100 ml containing 500 nM of each primer, 200 mM dNTPs, 1Â HF buffer and 2 units iProof (Bio-Rad) and run with the cycle: 98 1C for 30 s, 8 cycles of 98 1C for 10 s/67 1C for 15s/72 1C for 15 s, then 72 1C for 5 min. PCR product was purified with QiaQuick PCR clean-up kit.
The MspI control library was constructed in the same manner as the HpaII library, with the following changes: (i) in the first step 40 units of MspI (NEB) were used in place of HpaII and NEBuffer 2 was used instead of NEBuffer 1; and (ii) no amplification was done after gel purification.
The inverse library was constructed in this manner: HpaII digestion was performed as done in the HpaII library. After this, 10 units Antarctic Phosphatase (NEB) and 11 ml 10Â Antarctic Phosphatase Buffer (NEB) were added to the mixture, which was then incubated at 37 1C for 1 h, and 65 1C for 15 min. DNA was purified with phenol:chloroform followed by ethanol precipitation. The DNA was then resuspended and treated in the same manner as the MspI control library.
MSCC sequencing and read placement. In total, three lanes of sequencing were performed using an Illumina Genome Analyzer: two for the first technical replicate and one for the second technical replicate. These reads each contained sequence from the adapters and an 18-19 bp 'tag' derived from genomic sequence.
To match sequences, a list of all possible tags was created from all CCGG sites in the human genome (hg18, downloaded from UCSC). Tags were considered unique (later used for profiling) if no identical or single-mismatch tags existed, the neighboring HpaII site was at least 40 bp distant and there were no conflicting MmeI recognition sites. An in-house program was used to find all tag matches within 0-, 1-or 2-base distances. Reads were accepted if they were an exact match and no single mismatches could be made, or if there was no exact match, a single mismatch and no double mismatches existed. Counts or observations are the number of times a particular location was matched by a read (Supplementary Table 7) . MSCC data analysis. To validate MSCC data we compared it with BSPP data collected for a set of 381 shared CpG locations (726 total tags) to get ''counts versus methylation'' information. These data points were binned according to methylation to form 20 bins with 36 or 37 data points each and the average counts versus average methylation was plotted. We expect average counts to be linearly related to methylation with the equation: methylation ¼ a * counts -1. A best fit for this equation to the average data points was produced with a ¼ -0.1124. This was used to infer methylation when plotting average counts information.
Positions relative to genes for each MSCC site were calculated as before, using the RefGene list from UCSC. For multiple possible starts/ends, only the first entry was used. Using expression data genes were split into five equally sized groups based on gene expression levels. Running averages of MSCC counts were made for each graph: an interval of 5,000 data points for Figure 2b , an interval of 5,000 data points and 500 bp minimum window size for 2c and 2d and 500 data points with 500 bp minimum and 2,000 bp maximum windows for Figure 3 . Counts were normalized for local CpG density (surrounding 200 bp), for MspI control library counts, and, for the in-gene locations in Figure 2b , for gene length. To exclude data from gene promoter regions, only genes at least 15 kb in length were used to generate Figure 2d .
To analyze promoters based on CpG density, promoters were split into three types based on CpG density. Looking within the interval of -0.5 kb to +2 kb relative to transcription start (based on refGene annotation): high CpG promoters contain a 500-bp interval with a GC content of at least 0.55 and a CpG observed/expected ratio of at least 0.75, low CpG promoters contained no 500-bp interval with a CpG observed/expected ratio of at least 0.48, and all remaining promoters were defined as intermediate CpG promoters. Of 17,546 promoters analyzed, 11,445 (65%) were defined as HCP, 2,849 (16%) were defined as ICP, and 3,252 were defined as LCP (28%).
Methylation profiles for individual genes were created by finding average MSCC counts in the promoter region (defined as -400 to +1,000 bp) and in the gene body (defined as +3,000 bp to the end). Only genes with at least 10 MSCC data points in each region were plotted.
Accession numbers. Short reads (with quality scores) have been uploaded to the SRA (short read archive) databases at NCBI under accession number SRA008183.
Note: Supplementary information is available on the Nature Biotechnology website.
